言語:
日文
English
簡体中文
繁體中文
ヘルプ
ログイン
ホームページ
スイッチ:
ラベル
|
MARC形式
|
国際標準書誌記述(ISBD)
Genome editing[electronic resource] /
~
SpringerLink (Online service)
Genome editing[electronic resource] /
レコード種別:
コンピュータ・メディア : 単行資料
[NT 15000414] null:
576.5
タイトル / 著者:
Genome editing/ edited by Kursad Turksen.
その他の著者:
Turksen, Kursad.
出版された:
Cham : : Springer International Publishing :, 2016.
記述:
ix, 166 p. : : ill., digital ;; 24 cm.
含まれています:
Springer eBooks
主題:
Genetic engineering.
主題:
Stem cells.
主題:
Life Sciences.
主題:
Regenerative Medicine/Tissue Engineering.
主題:
Stem Cells.
主題:
Animal Genetics and Genomics.
国際標準図書番号 (ISBN) :
9783319341484
国際標準図書番号 (ISBN) :
9783319341460
[NT 15000228] null:
Genome Editing with Targetable Nucleases -- CRISPR/Cas9 Approaches to Investigate the Non-coding Genome -- At the Conflux of Human Genome Engineering and Induced Pluripotency -- CRISPR/Cas9 and the Paradigm Shift in Mouse Genome Manipulation Technologies -- Genome Editing Technology in CRISPR/Cas System: How to Increase Knock-in Efficiency in Mouse Zygotes -- Developments in the Generation of Reporter Stem Cells -- Current Status of Genome Editing in Cardiovascular Medicine -- Using CRISPR-Cas9 Genome Editing to Enhance Cell Based Therapies for the Treatment of Diabetes Mellitus -- Genome Editing in the Retina: a Case Study in CRISPR for a Patient-Specific Autosomal Dominant Retinitis Pigmentosa Model -- Index.
[NT 15000229] null:
This timely volume explores the use of CRISPR-Cas9 for genome editing, presenting cutting-edge techniques and their applications in treatment of disease. The chapters describe latest methods such as use of targetable nucleases, investigation of the non-coding genome, mouse genome editing, increasing of knock-in efficiency in mouse zygotes, and generation of reporter stem cells; the text contextualizes these methods in treatment of cardiovascular disease, diabetes mellitus, retinitis pigmentosa, and others. The final chapters round out the book with a discussion of controversies and future directions. Genome Editing is an essential, of-the-moment contribution to this rapidly growing field. Drawing from a wealth of international perspectives, it presents novel techniques and applications for the engineering of the human genome. This book is essential reading for all clinicians and researchers in stem cells, regenerative medicine, genomics, biochemical and biomedical engineering- especially those interested in learning more about genome editing and applying it in a targeted, specific way.
電子資源:
http://dx.doi.org/10.1007/978-3-319-34148-4
Genome editing[electronic resource] /
Genome editing
[electronic resource] /edited by Kursad Turksen. - Cham :Springer International Publishing :2016. - ix, 166 p. :ill., digital ;24 cm.
Genome Editing with Targetable Nucleases -- CRISPR/Cas9 Approaches to Investigate the Non-coding Genome -- At the Conflux of Human Genome Engineering and Induced Pluripotency -- CRISPR/Cas9 and the Paradigm Shift in Mouse Genome Manipulation Technologies -- Genome Editing Technology in CRISPR/Cas System: How to Increase Knock-in Efficiency in Mouse Zygotes -- Developments in the Generation of Reporter Stem Cells -- Current Status of Genome Editing in Cardiovascular Medicine -- Using CRISPR-Cas9 Genome Editing to Enhance Cell Based Therapies for the Treatment of Diabetes Mellitus -- Genome Editing in the Retina: a Case Study in CRISPR for a Patient-Specific Autosomal Dominant Retinitis Pigmentosa Model -- Index.
This timely volume explores the use of CRISPR-Cas9 for genome editing, presenting cutting-edge techniques and their applications in treatment of disease. The chapters describe latest methods such as use of targetable nucleases, investigation of the non-coding genome, mouse genome editing, increasing of knock-in efficiency in mouse zygotes, and generation of reporter stem cells; the text contextualizes these methods in treatment of cardiovascular disease, diabetes mellitus, retinitis pigmentosa, and others. The final chapters round out the book with a discussion of controversies and future directions. Genome Editing is an essential, of-the-moment contribution to this rapidly growing field. Drawing from a wealth of international perspectives, it presents novel techniques and applications for the engineering of the human genome. This book is essential reading for all clinicians and researchers in stem cells, regenerative medicine, genomics, biochemical and biomedical engineering- especially those interested in learning more about genome editing and applying it in a targeted, specific way.
ISBN: 9783319341484
Standard No.: 10.1007/978-3-319-34148-4doiSubjects--Topical Terms:
223322
Genetic engineering.
LC Class. No.: QH442
Dewey Class. No.: 576.5
Genome editing[electronic resource] /
LDR
:02720nmm a2200313 a 4500
001
465357
003
DE-He213
005
20160809154433.0
006
m d
007
cr nn 008maaau
008
170411s2016 gw s 0 eng d
020
$a
9783319341484
$q
(electronic bk.)
020
$a
9783319341460
$q
(paper)
024
7
$a
10.1007/978-3-319-34148-4
$2
doi
035
$a
978-3-319-34148-4
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QH442
072
7
$a
PSF
$2
bicssc
072
7
$a
SCI049000
$2
bisacsh
082
0 4
$a
576.5
$2
23
090
$a
QH442
$b
.G335 2016
245
0 0
$a
Genome editing
$h
[electronic resource] /
$c
edited by Kursad Turksen.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
ix, 166 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Genome Editing with Targetable Nucleases -- CRISPR/Cas9 Approaches to Investigate the Non-coding Genome -- At the Conflux of Human Genome Engineering and Induced Pluripotency -- CRISPR/Cas9 and the Paradigm Shift in Mouse Genome Manipulation Technologies -- Genome Editing Technology in CRISPR/Cas System: How to Increase Knock-in Efficiency in Mouse Zygotes -- Developments in the Generation of Reporter Stem Cells -- Current Status of Genome Editing in Cardiovascular Medicine -- Using CRISPR-Cas9 Genome Editing to Enhance Cell Based Therapies for the Treatment of Diabetes Mellitus -- Genome Editing in the Retina: a Case Study in CRISPR for a Patient-Specific Autosomal Dominant Retinitis Pigmentosa Model -- Index.
520
$a
This timely volume explores the use of CRISPR-Cas9 for genome editing, presenting cutting-edge techniques and their applications in treatment of disease. The chapters describe latest methods such as use of targetable nucleases, investigation of the non-coding genome, mouse genome editing, increasing of knock-in efficiency in mouse zygotes, and generation of reporter stem cells; the text contextualizes these methods in treatment of cardiovascular disease, diabetes mellitus, retinitis pigmentosa, and others. The final chapters round out the book with a discussion of controversies and future directions. Genome Editing is an essential, of-the-moment contribution to this rapidly growing field. Drawing from a wealth of international perspectives, it presents novel techniques and applications for the engineering of the human genome. This book is essential reading for all clinicians and researchers in stem cells, regenerative medicine, genomics, biochemical and biomedical engineering- especially those interested in learning more about genome editing and applying it in a targeted, specific way.
650
0
$a
Genetic engineering.
$3
223322
650
0
$a
Stem cells.
$3
412365
650
1 4
$a
Life Sciences.
$3
463509
650
2 4
$a
Regenerative Medicine/Tissue Engineering.
$3
588523
650
2 4
$a
Stem Cells.
$3
412367
650
2 4
$a
Animal Genetics and Genomics.
$3
465168
700
1
$a
Turksen, Kursad.
$3
467846
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-34148-4
950
$a
Biomedical and Life Sciences (Springer-11642)
~に基づいて 0 論評
マルチメディア (複合媒体資料)
マルチメディアファイル
http://dx.doi.org/10.1007/978-3-319-34148-4
論評
論評を追加
あなたの考えを共有してください。
Export
受取館
処理
...
パスワードを変更する
ログイン